SEC filing record
Primary Source · SEC.gov

OurCrowd (Investment in BiScience) LP

Single-Deal SPV2017 vintage506(c), 3(c)(1)

Raised

$20K

Investors

2

Min Invest

$10,000

AltStreet Verified Issuer badge

Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.

AltStreet Analysis

·

Generated from EDGAR primary sources

OurCrowd (Investment in BiScience) LP is a single-deal special purpose vehicle formed to channel investor capital into a company called BiScience, filed by OurCrowd-affiliated executives Jonathan Medved, Steven Blumgart, Jay Kalish, and Robert Citron. The filing reports $20K raised from 2 investors at a $10K minimum investment, under combined Rule 506(c) and Section 3(c)(1) exemptions, with no first sale date disclosed.

This is a small single-deal SPV within the alternative investment category, using the dual 506(c)/3(c)(1) exemption structure common to pooled investment vehicles targeting accredited investors. At a $10K minimum and $20K total raise, this offering is substantially smaller in scale than typical institutional alternative investment funds, consistent with an early or partial close on a narrow-purpose investment vehicle.

Data Flags

First Sale DateNo first sale date is disclosed despite this being a small ($20K) offering well under $100M, which is the threshold where missing sale dates become expected for large institutional amendments.
State of IncorporationEntity is domiciled in the British Virgin Islands, an offshore jurisdiction, while filing a U.S. Form D — indicating a cross-border fund structure.
ExemptionFiling claims both Rule 506(c) and Section 3(c)(1) exemptions simultaneously, a combined-exemption pattern seen in some pooled fund templates.

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001657190
Entity NameOurCrowd (Investment in BiScience) LP
ExemptionRule 506(c), Section 3(c), Section 3(c)(1)
What the exemption meansRule 506(c) of Regulation D: the issuer may advertise the offering publicly, but every purchaser must be a verified accredited investor. Section 3(c) of the Investment Company Act of 1940: the issuer is a pooled investment vehicle relying on an exclusion from registration as an investment company. Section 3(c)(1) of the Investment Company Act: the fund is excluded from investment-company registration because it has no more than 100 beneficial owners.
Entity TypeLimited Partnership
Jurisdiction of OrganizationVirgin Islands, British
Year Organized2015
Issuer Address28 Derech Hebron, Jerusalem, L3 9108001
Phone972-2-636-9300
Industry / Fund TypePooled Investment Fund · Venture Capital Fund
Investment Company ActExcluded under Section 3(c)(1) (100 beneficial owners or fewer)
Securities TypeEquity, Pooled Investment Fund
First Sale Date—
Filing DateMarch 1, 2017
Accession Number0001465818-17-000007
Total Offering AmountIndefinite
Total Amount Sold$20,000
Total Investors2
Non-Accredited InvestorsNone
Minimum Investment$10,000
Offering DurationOne year or less
Sales Commissions$0
Finders' Fees$0
Revenue RangeNot Applicable
State (Issuer Address)L3
Amendment Count2 filings on record

Filings on Record

Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.

In the Terminal

Filing events

0

none on file

Critical / warning

0 / 0

0 watch · 0 info

Statements extracted

0

none on file

NAV prints

0

none on file

Offering chains

1

lapsed

Open in the terminal Watch this issuerInvestor $149/mo unlocks the values; Pro $349/mo adds the universe.

Fund family Part of the OurCrowd family: 475 vehicles across 41 generations · full family and the filing behind each link in the terminal

Investor

  • The full fund family and any related vehicles (parallel, feeder, successor, sibling series) with the filing that shows each link
  • 1 offering timeline: velocity, share raised, first-sale lag, stalled flags

Pro

  • This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
  • The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV

Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Jonathan Medved

Executive Officer, Director · Jerusalem, L3

Steven Blumgart

Executive Officer, Director · Jerusalem, L3

Jay Kalish

Executive Officer · Jerusalem, L3

Robert Citron

Executive Officer · Jerusalem, L3

Questions About OurCrowd (Investment in BiScience) LP

Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.

What is OurCrowd (Investment in BiScience) LP?

OurCrowd (Investment in BiScience) LP is a Virgin Islands, British limited partnership organized in 2015 that filed a Form D with the SEC on March 1, 2017 as a venture capital fund. The filing claims Rule 506(c), Section 3(c), Section 3(c)(1) for an offering of equity and pooled investment fund interests.

Is OurCrowd (Investment in BiScience) LP legit?

AltStreet does not rate legitimacy; it reports the public record. OurCrowd (Investment in BiScience) LP filed a Form D with the SEC on March 1, 2017 claiming Rule 506(c), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $20,000 sold to 2 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.

Is OurCrowd (Investment in BiScience) LP registered with or approved by the SEC?

No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that OurCrowd (Investment in BiScience) LP claimed Rule 506(c), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.

How much has OurCrowd (Investment in BiScience) LP raised?

OurCrowd (Investment in BiScience) LP reported $20,000 sold from 2 investors in an offering of indefinite size as of the Form D filed March 1, 2017.

Who can invest in OurCrowd (Investment in BiScience) LP?

The offering relies on Rule 506(c), so the issuer may advertise it but may sell only to investors it has verified as accredited. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $10,000.

What is the minimum investment in OurCrowd (Investment in BiScience) LP?

The Form D lists $10,000 as the minimum investment accepted from any outside investor as of March 1, 2017. Issuers can waive their own minimums, and the figure does not include fees.

Who is selling OurCrowd (Investment in BiScience) LP and how are they paid?

The Form D names no recipient of sales compensation, which usually means the issuer or its affiliates are placing the securities directly. Sales commissions are reported as $0 and finders' fees as $0. Form D allows these to be estimates.

Who is behind OurCrowd (Investment in BiScience) LP?

The Form D lists 4 related persons: Jonathan Medved, executive officer, director (Mr. Medved is Managing Partner of the General Partner, OurCrowd International General Partner, LP); Steven Blumgart, executive officer, director (Mr. Blumgart is Managing Partner of the General Partner); Jay Kalish, executive officer (Mr. Kalish is Partner and General Counsel of the General Partner); Robert Citron, executive officer (Mr. Citron is CFO of the General Partner). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.

Where is OurCrowd (Investment in BiScience) LP located?

The issuer's address on its SEC filings is 28 Derech Hebron, Jerusalem, L3 9108001. Its phone number of record is 972-2-636-9300. It is organized under the laws of Virgin Islands, British.

How long is the OurCrowd (Investment in BiScience) LP offering open?

The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open, and no amendment is on record yet.

How large is OurCrowd (Investment in BiScience) LP?

The Form D reports a revenue range of Not Applicable.

AltStreet Verified Issuer badge

Is this your company or fund?

Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.

Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.